E D I T O R I A L Editorial to 'Antibiotic envelope is associated with reduction in cardiac implantable electronic devices infections especially for high-power device-Systematic review and meta-analysis'
The infection of cardiovascular implantable electronic device (CIED) infection was 1.9/1000 device-years, with an incidence of pocket infection alone of 1.37/1000 device-years and an incidence of pocket infection with bloodstream infection or device related endocarditis of 1.14/1000 device-years. Especially, the cumulative probability of CIED infection was higher among patients with implantable cardioverter defibrillator (ICD) as compared to those with permanent pacemarker (PPM). 1 Risk factor of CIED infection were diabetes mellitus, heart failure, generator replacement, renal dysfunction. In addition, oral anticoagulant usage, long-term corticosteroid usage, and the presence of more than 2 pacing leads were identified as independent correlates of device infection. 2 In the article published in This meta-analysis may be a starting point to state the effect of using antibiotic envelops for patients with high power device having risk factor of device infection. Further studies will be needed to certain the relationship between device infection and antibiotic envelops (TYRX) with long-term follow-up period.
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